U.S. flag

An official website of the United States government

NM_000171.4(GLRA1):c.896G>T (p.Arg299Leu) AND Hereditary hyperekplexia

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Nov 24, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002228030.5

Allele description [Variation Report for NM_000171.4(GLRA1):c.896G>T (p.Arg299Leu)]

NM_000171.4(GLRA1):c.896G>T (p.Arg299Leu)

Gene:
GLRA1:glycine receptor alpha 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q33.1
Genomic location:
Preferred name:
NM_000171.4(GLRA1):c.896G>T (p.Arg299Leu)
Other names:
R271L
HGVS:
  • NC_000005.10:g.151851406C>A
  • NG_011764.1:g.78431G>T
  • NM_000171.4:c.896G>TMANE SELECT
  • NM_001146040.2:c.896G>T
  • NM_001292000.2:c.647G>T
  • NP_000162.2:p.Arg299Leu
  • NP_001139512.1:p.Arg299Leu
  • NP_001278929.1:p.Arg216Leu
  • NC_000005.9:g.151230967C>A
  • NM_000171.3:c.896G>T
  • P23415:p.Arg299Leu
Nucleotide change:
G1192T
Protein change:
R216L; ARG271LEU
Links:
UniProtKB: P23415#VAR_000298; OMIM: 138491.0001; dbSNP: rs121918408
NCBI 1000 Genomes Browser:
rs121918408
Molecular consequence:
  • NM_000171.4:c.896G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001146040.2:c.896G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001292000.2:c.647G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary hyperekplexia
Synonyms:
Hyperexplexia, hereditary
Identifiers:
MONDO: MONDO:0021022; MedGen: C1835614; OMIM: PS149400

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000813243Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Nov 24, 2023)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Startle disease mutations reduce the agonist sensitivity of the human inhibitory glycine receptor.

Rajendra S, Lynch JW, Pierce KD, French CR, Barry PH, Schofield PR.

J Biol Chem. 1994 Jul 22;269(29):18739-42.

PubMed [citation]
PMID:
7518444

Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia.

Shiang R, Ryan SG, Zhu YZ, Hahn AF, O'Connell P, Wasmuth JJ.

Nat Genet. 1993 Dec;5(4):351-8.

PubMed [citation]
PMID:
8298642
See all PubMed Citations (7)

Details of each submission

From Invitae, SCV000813243.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 299 of the GLRA1 protein (p.Arg299Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant hyperekplexia (PMID: 8298642; Invitae). This variant is also known as p.Arg271Leu. ClinVar contains an entry for this variant (Variation ID: 16060). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GLRA1 protein function. Experimental studies have shown that this missense change affects GLRA1 function (PMID: 7518444). This variant disrupts the p.Arg299 amino acid residue in GLRA1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 8298642, 8733061, 19073849, 28122427, 28138086). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024